NOTE 8: - OPERATING SEGMENTS

The Company operates in three segments, Agriculture, Industry and Human. The Agriculture segment consists of the parent company, Evogene, Evogene’s subsidiary AgPlenus Ltd., and the activities of Lavie Bio Ltd. that are classified as continuing operations. The Industry segment consists of Evogene’s subsidiary Casterra Ag Ltd. The Human segment consists of certain activities of Evogene’s subsidiary Biomica Ltd. that are classified as continuing operations. The activities of Lavie Bio Ltd. and Biomica Ltd. classified as discontinued operations are presented separately under “Loss from discontinued operations, net” in the consolidated interim statement of profit or loss.

The segments were determined on the basis of information considered by the Chief Operating Decision-Maker (“CODM”) for purposes of decision-making on the allocation of resources and evaluation of performance. The following Company's segments are engaged in business activities for which they earn revenues and incur expenses, their results are reviewed by the CODM and discrete financial information is available:

Each segment’s performance is determined based on operating loss reported in the financial statements. The results of a segment reported to the CODM include items attributed directly to a segment, as well as other items, which are indirectly attributed using reasonable assumptions.

Detailed below are revenues from major customers each of which accounts for 10% or more, of total revenues:

During the six months ended June 30, 2026 and 2025, the Company did not enter into any collaboration agreements which amount to 10% or more of its total revenues for the period ended June 30, 2026 and June 30, 2025.